Cargando…
Long-term use of metformin and the molecular subtype in invasive breast carcinoma patients – a retrospective study of clinical and tumor characteristics
BACKGROUND: Metformin may exhibit inhibitory effects on cancer cells by inhibiting mTOR signaling pathway. The aim of our retrospective study was to examine if patients with breast carcinoma (BC) and diabetes mellitus (DM) receiving metformin have a lower stage of carcinoma in comparison to patients...
Autores principales: | Besic, Nikola, Satej, Nika, Ratosa, Ivica, Horvat, Andreja Gojkovic, Marinko, Tanja, Gazic, Barbara, Petric, Rok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005811/ https://www.ncbi.nlm.nih.gov/pubmed/24774412 http://dx.doi.org/10.1186/1471-2407-14-298 |
Ejemplares similares
-
Prognostic factors for disease-specific survival in 108 patients with Hürthle cell thyroid carcinoma: a single-institution experience
por: Petric, Rok, et al.
Publicado: (2014) -
Insulin glargine versus other types of basal insulin–clinical and tumor characteristics in patients with breast carcinoma
por: Besic, Nikola, et al.
Publicado: (2013) -
Expression of miRNA and Occurrence of Distant Metastases in Patients with Hürthle Cell Carcinoma
por: Petric, Rok, et al.
Publicado: (2016) -
Neoadjuvant chemotherapy in 13 patients with locally advanced poorly differentiated thyroid carcinoma based on Turin proposal - a single institution experience
por: Besic, Nikola, et al.
Publicado: (2015) -
Dietary Iodine Intake, Therapy with Radioiodine, and Anaplastic Thyroid Carcinoma
por: Besic, Nikola, et al.
Publicado: (2020)